PPARG and type 2 diabetes mellitus: For example, db/db mice were characterized by a lower level of Pparγ promoter methylation in subcutaneous adipose tissue, but by an increased level in visceral adipose tissue [28]; on the other hand, in humans with type 2 diabetes, methylation of Pparγ promoter was increased in terms of SAT compared to healthy subjects [29].